Details of the Drug Formulaction

General Information of Drug Formulation (ID: F18692)

Formulation Name
Raltegravir 25 mg tablet
Company
Merck Sharp & Dohme
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Raltegravir DMYURI6 Human immunodeficiency virus infection 1C62 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Ammonia E00007 222 Alkalizing agent
Aspartame E00402 134601 Flavoring agent
Ferric hydroxide oxide yellow E00539 23320441 Colorant
Fructose E00447 2723872 Flavoring agent
Hexahydric alcohol E00083 5780 Diluent; Flavoring agent; Humectant; Plasticizing agent
Magnesium stearate E00208 11177 lubricant
Mannitol E00103 6251 Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Medium-chain triglyceride E00640 Not Available Emollient; Lubricant; Surfactant
Monoammonium glycyrrhizate E00352 62074 Emulsifying agent; Flavoring agent
Oleic acid E00421 445639 Emulsifying agent; Penetration agent; Solubilizing agent
Polyethylene glycol 400 E00653 Not Available Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Sodium citrate dihydrate E00369 71474 Alkalizing agent; Buffering agent; Complexing agent; Emulsifying agent
Sodium stearyl fumarate E00545 23665634 lubricant
Sucralose E00370 71485 Flavoring agent